Globus Medical
GMED
290 hedge funds and large institutions have $3.27B invested in Globus Medical in 2018 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 102 increasing their positions, 94 reducing their positions, and 36 closing their positions.
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
33% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 36
6% more capital invested
Capital invested by funds: $3.08B → $3.27B (+$191M)
4% more funds holding
Funds holding: 279 → 290 (+11)
1.77% more ownership
Funds ownership: 85.45% → 87.22% (+1.8%)
9% more repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 94
48% less call options, than puts
Call options by funds: $12.1M | Put options by funds: $23.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$62.1M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$58.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.4M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$48.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$71.1M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$55.4M |
| 3 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$39.2M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$24.9M |
| 5 |
ACA
Anchor Capital Advisors
Boston,
Massachusetts
|
-$22.2M |
GMED Hedge Fund Activity: Q2 2018 in Review
290 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2018, worth a combined $3.27B — up 6.2% from $3.08B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new GMED positions and 36 closed out — a net gain of 12 holders — while 102 added to existing stakes and 94 trimmed.
The largest buyer was BlackRock, adding an estimated $62.1M. The largest seller was Janus Henderson Group, cutting an estimated $71.1M.
- 290 institutional investors held Globus Medical (GMED) as of Q2 2018, up from 279 in Q1 2018.
- Funds reported $3.27B of Globus Medical stock for Q2 2018, up 6.2% quarter-over-quarter.
- 48 funds opened new Globus Medical positions in Q2 2018 and 36 closed out, a net change of +12 holders.
- The largest Globus Medical buyer in Q2 2018 was BlackRock, an estimated $62.1M added.
- The largest Globus Medical seller in Q2 2018 was Janus Henderson Group, an estimated $71.1M sold.
Based on aggregated 13F filings for Q2 2018.